ClinConnect ClinConnect Logo
Search / Trial NCT06338631

Early Detection of Renal Abnormalities in Metabolically Healthy and Unhealthy Weight Excess"

Launched by ISTITUTO AUXOLOGICO ITALIANO · Mar 24, 2024

Trial Information

Current as of August 19, 2025

Recruiting

Keywords

Metabolic Phenotype Renal Function

ClinConnect Summary

This clinical trial is studying how being overweight or obese affects kidney health, specifically looking at two groups: those who are metabolically healthy despite their weight and those who are not. Researchers want to understand if these different metabolic conditions lead to varying levels of kidney function or damage. They will include 1,000 patients aged 18 to 60 who have a body mass index (BMI) of at least 25 kg/m². People who are pregnant, have diabetes, or certain other health conditions won’t be able to participate.

If you join this study, you’ll help researchers learn more about how diet and processed foods might influence kidney health in people with obesity. The trial is observational, which means you won’t be receiving any treatments, but rather your health will be monitored over time. Participating could help improve our understanding of how to better care for individuals struggling with weight and kidney issues in the future.

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • Age between 18 and 60 years
  • BMI at least 25 kg/m2
  • Exclusion Criteria:
  • Pregnancy or breastfeeding
  • Diabetes mellitus
  • Renal disease
  • Systemic autoimmune diseases with possible renal involvement
  • Agonistic physical activity
  • Heart failure
  • Pharmacologcal treatment with RAAS-inhibitors, sartans, thiazide diuretics, loop diuretics
  • Urinary tract infection

About Istituto Auxologico Italiano

Istituto Auxologico Italiano is a prominent Italian research institute dedicated to advancing medical science and improving patient care through innovative clinical research. With a strong focus on metabolic diseases, cardiovascular health, and neuropsychological disorders, the institute integrates clinical practice with cutting-edge research to foster the development of new therapeutic strategies. Committed to ethical standards and patient safety, Istituto Auxologico Italiano collaborates with various national and international partners, contributing significantly to the global medical community while ensuring high-quality care and support for its patients.

Locations

Milano, , Italy

Naples, , Italy

Patients applied

0 patients applied

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported